Breaking News

You are here » Indian-Commodity  :  Top News  :  Granules India receives USFDA approval for Metformin ER Tablets

20-Mar2018

Granules India receives USFDA approval for Metformin ER Tablets

Granules India has received approval from the US Food & Drug Administration (USFDA) for Abbreviated New Drug Application (ANDA) for Metformin Extended Release (ER) Tablets 500 mg and 750 mg. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Glucophage XR tablets of Bristol Myers Squibb. The company intends to commercialize this product shortly.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).




Related News

View all news

Copper futures end tad higher on Monday

Copper futures ended slightly higher on Monday, with hopes of a resolution to the US-China trade war outweighing the threat of higher US tariffs on Chinese goods. Copper prices improved further as the......

Gold futures extend winning streak to fourth straight session on Monday

Gold futures extended winning streak to fourth straight session by registering small gains on Monday, amid geopolitical uncertainty and an eased greenback. However, gains were limited due to thin volume......

Physical Rubber prices witness weakness on Monday

Physical Rubber prices showed weakness on Monday amidst dull volumes in the market. Spot prices for RSS-4 variety fell to Rs 120.50/ kg compared to its previous closing of Rs 121/ kg; while the RSS-5 variety......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......